In a recent study, a droplet digital ExoELISA method was developed for the detection of GPC-1(+) exosomes in clinical samples from healthy individuals, patients with benign breast cancer, patients with breast cancer, and post-breast cancer patients. Here, GPC1 is linked to breast cancer.